8-K: Centrus Energy Secures $110 Million DOE Contract Extension for HALEU Production

Centrus Energy Corp. announced a significant contract amendment with the U.S. Department of Energy, securing a one-year extension valued at approximately $110 million for High-Assay, Low-Enriched Uranium (HALEU) production through June 30, 2026.

Summary

• Centrus Energy Corp., through its wholly owned subsidiary American Centrifuge Operating, LLC (ACO), secured an amendment to its High-Assay, Low-Enriched Uranium (HALEU) Demonstration Cascade Completion and HALEU Operation Contract with the U.S. Department of Energy (DOE).
• The amendment, issued on June 17, 2025, splits the first three-year option period (Option 1) into a one-year period (Option 1a) and a two-year period (Option 1b).
• The DOE has exercised Option 1a, valued at approximately $110,000,000, extending the period of performance to June 30, 2026.
• Option 1a has a target cost of $99,289,528 and a target fee of $8,704,218.
• For Option 1b, with a target cost of $163,477,542 and a target fee of $15,235,927, the estimated cost is acknowledged as insufficient due to known cost increases, requiring ACO to submit a revised cost proposal for review and negotiation.
• The original contract included three three-year option periods for up to nine additional years of production at an expected annual rate of 900 kilograms of HALEU, subject to DOE discretion and Congressional appropriations.
• Centrus previously completed Phase I of the contract in late 2023 by demonstrating production and delivery of 20 kilograms of 19.75% enriched HALEU.
• Phase II of the contract called for Centrus to produce an additional 900 kilograms of HALEU by June 30, 2025.
• The HALEU produced under this contract belongs to the Department of Energy.

Sentiment

Score: 8

Explanation: The contract extension is a significant positive development, securing substantial revenue and demonstrating continued government commitment to Centrus's HALEU program. While there's a minor negative regarding the insufficient cost estimate for Option 1b, the overall outlook is strong due to the immediate funding and long-term potential in a strategically important sector.

Positives

• Centrus secured a significant contract extension (Option 1a) with the U.S. Department of Energy, valued at approximately $110 million.
• The extension ensures continued HALEU production through June 30, 2026, providing revenue and operational continuity for the company's critical program.
• The contract retains additional options for up to eight more years of HALEU production, indicating strong long-term potential and continued government commitment to domestic HALEU supply.
• Centrus is actively delivering meaningful quantities of HALEU, which is essential for catalyzing a new generation of advanced reactors and establishing a U.S.-owned uranium enrichment capability.
• The extension reflects the ongoing value of the partnership between Centrus and the DOE in restoring America's ability to enrich uranium for national security and clean energy needs.

Negatives

• The estimated cost associated with Option 1b is acknowledged as insufficient due to known cost increases, requiring Centrus to submit a revised cost proposal for review and negotiation, which could potentially lead to delays or less favorable terms for that option.

Risks

• Risks related to the DOE not exercising options following the completion of Option 1a performance period or awarding a third party to continue the HALEU Operation Contract.
• Risks related to changes to the U.S. government's appropriated funding levels for the HALEU Operation Contract due to changes in U.S. government policy or other reasons.
• Risks related to whether or when government funding or demand for HALEU for government or commercial uses will materialize and at what level.
• Risks regarding funding for continuation and deployment of the American Centrifuge technology.
• Risks related to Centrus's ability to perform and absorb costs under the HALEU Operation Contract, and its ability to obtain new contracts and funding to continue operations.
• Risks that Centrus may not obtain the full benefit of the HALEU Operation Contract and may not be able or allowed to operate the HALEU enrichment facility to produce HALEU after the completion of the contract, or that the output may not be available as a future source of supply.
• Risks related to pricing trends and demand in the uranium and enrichment markets and their impact on profitability.
• Risks related to the DOE not issuing any major task orders to any contract awardee under the HALEU Production Contract, LEU Production Contract, or HALEU Deconversion Contract.
• Risks related to Centrus not winning a task order under the HALEU Production Contract, LEU Production Contract, and HALEU Deconversion Contract to expand the capacity of the American Centrifuge plant.
• Risks related to the DOE not providing an adequate share of the appropriated funding to Centrus under any of the HALEU Production Contract, LEU Production Contract, or HALEU Deconversion Contract.
• Risks related to Centrus's ability to secure financing to expand its plant for LEU or HALEU or expand it to a commercially viable level.
• Risks related to Centrus's inability to increase capacity for HALEU or LEU in a timely manner to meet market demand or contractual obligations.
• Risks related to the DOE not awarding any contracts to Centrus in response to future proposals.
• Risks related to a government shutdown or lack of funding that could result in program cancellations, disruptions, and/or stop work orders, and could limit the U.S. government's ability to make timely payments.
• Risks related to uncertainty regarding Centrus's ability to commercially deploy competitive enrichment technology.
• Risks related to the potential for demobilization or termination of the HALEU Operation Contract.
• Risks that Centrus will not be able to timely complete the work it is obligated to perform.
• Risks related to the government's inability to satisfy its obligations, including supplying government furnished equipment necessary for HALEU production and processing security clearance applications.
• Risks related to Centrus's inability to obtain the government's approval to extend the term of, or the scope of permitted activities under, its lease with the DOE in Piketon, Ohio.
• Risks related to cybersecurity incidents that may impact business operations.
• Risks related to Centrus's inability to perform fixed-price and cost-share contracts, including the risk that costs could be higher than expected and the risk related to complying with stringent government contractual requirements.
• Risks related to Centrus's inability to attract qualified employees necessary for the potential expansion of operations in Oak Ridge, Tennessee, or Piketon, Ohio.
• Risks related to actions, including investigations, reviews or audits, that may be taken by the U.S. government, the Russian government, or other governments that could affect Centrus's ability to perform under contractual obligations or the ability of its sources of supply.
• Risks related to Centrus's inability to perform and receive timely payment under its agreements with the DOE or other government agencies, including risks related to ongoing funding and potential audits.
• Risks related to how aligned Centrus may be, or perceived to be, with any political party, administration, or its policies.
• Risks related to changes or termination of agreements with the U.S. government or other counterparties, or the exercise of contract remedies by such counterparties.
• Risks related to changes in the nuclear energy industry.
• Risks related to the competitive bidding process associated with obtaining contracts, including government contracts.
• Risks related to potential strategic transactions that could be difficult to implement, disrupt business, or significantly change the business profile.
• Risks related to the outcome of legal proceedings and other contingencies (including lawsuits and government investigations or audits).
• Risks related to the impact of, or changes to, government regulation and policies or interpretation of laws or regulations.
• Risks related to the recent U.S. federal government administration's reliance on executive orders to implement regulatory or trade policy and objectives, which could exacerbate regulatory or, private or public, financing unpredictability.

Future Outlook

The Department of Energy has additional options for continued HALEU production for up to eight additional years beyond June 30, 2026, subject to their sole discretion and Congressional appropriations. Centrus aims to establish a large-scale, U.S.-owned uranium enrichment capability to meet commercial and national security requirements. However, the estimated cost for Option 1b is currently insufficient, requiring a revised proposal and negotiation before its consideration.

Management Comments

• "This extension reflects the ongoing value of the partnership that the Department launched with Centrus in 2019 to restore America's ability to enrich uranium and provide a source of HALEU that the Department and the nation urgently need." Amir Vexler, Centrus President and CEO.
• "We are delivering meaningful quantities of HALEU to catalyze a new generation of reactors, while laying the groundwork to establish a large-scale, U.S.-owned uranium enrichment capability to meet America's commercial and national security requirements." Amir Vexler, Centrus President and CEO.

Industry Context

This announcement highlights the U.S. government's continued commitment to developing a domestic supply chain for High-Assay, Low-Enriched Uranium (HALEU), which is critical for the deployment of advanced nuclear reactors. It underscores the strategic importance of Centrus Energy in national energy security and clean energy initiatives, positioning the company as a key player in the nascent advanced nuclear fuel market. The focus on HALEU production aligns with global efforts to diversify nuclear fuel sources and reduce reliance on foreign suppliers, particularly in light of geopolitical tensions and the need for carbon-free energy solutions.

Comparison to Industry Standards

• The document does not provide specific comparable companies, projects, or results to assess against global benchmarks. The HALEU production by Centrus is described as 'first-of-a-kind' in the U.S., making direct comparisons within the domestic context challenging.

Stakeholder Impact

• Shareholders: Positive impact due to secured revenue, extended contract visibility, and the company's enhanced strategic importance in the nuclear fuel market, potentially leading to increased share price.
• Employees: Positive impact due to continued operations at the American Centrifuge Plant in Piketon, Ohio, ensuring job security and potential for future expansion.
• Customers (DOE): Ensures continued supply of critical HALEU for advanced reactor development and national security needs, supporting U.S. energy independence.
• Suppliers: Continued demand for materials and services related to HALEU production, supporting the supply chain.
• Creditors: Improved financial stability and outlook, potentially enhancing the company's creditworthiness.

Next Steps

• Centrus's American Centrifuge Operating, LLC (ACO) will need to submit a revised cost proposal for Option 1b for review and negotiation with the Department of Energy.
• The Department of Energy has discretion to exercise additional three-year option periods for HALEU production, subject to Congressional appropriations, for up to eight additional years beyond June 30, 2026.
• Centrus aims to continue laying the groundwork to establish a large-scale, U.S.-owned uranium enrichment capability to meet national energy and security needs.

Key Dates

Recommendation

Keywords

Centrus Energy, HALEU, High-Assay, Low-Enriched Uranium, Department of Energy, DOE, Uranium Enrichment, Nuclear Fuel, Contract Extension, American Centrifuge Plant, Piketon Ohio, Nuclear Energy, Advanced Reactors, Energy Security